Cargando…
Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids
Multidrug resistance (MDR) resulting from different defensive mechanisms in cancer is one of the major obstacles of clinical treatment. To circumvent MDR many reversal agents have been developed, but most of them fail in clinical trials due to severely adverse effects. Recently, certain natural prod...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581719/ https://www.ncbi.nlm.nih.gov/pubmed/31245292 http://dx.doi.org/10.3389/fonc.2019.00487 |
_version_ | 1783428197549867008 |
---|---|
author | Ye, Qingmei Liu, Kai Shen, Qun Li, Qingyue Hao, Jinghui Han, Fangxuan Jiang, Ren-Wang |
author_facet | Ye, Qingmei Liu, Kai Shen, Qun Li, Qingyue Hao, Jinghui Han, Fangxuan Jiang, Ren-Wang |
author_sort | Ye, Qingmei |
collection | PubMed |
description | Multidrug resistance (MDR) resulting from different defensive mechanisms in cancer is one of the major obstacles of clinical treatment. To circumvent MDR many reversal agents have been developed, but most of them fail in clinical trials due to severely adverse effects. Recently, certain natural products have been reported to overcome MDR, including flavonoids which are abundant in plants, foods, and herbs. The structure of flavonoids can be abbreviated as C6-C3-C6 (C for carbon), and further categorized into flavonoids, iso-flavonoids and neo-flavonoids, according to their structural backbones. Flavonoids possess multiple bioactivities, and a growing body of research has indicated that both flavonoids and iso-flavonoids can either kill or re-sensitize conventional chemotherapeutics to resistant cancer cells. Here, we summarize the research and discuss the underlying mechanisms, concluding that these flavonoids do not function as specific regulators of target proteins, but rather as multi-functional agents that negatively regulate the key factors contributing to MDR. |
format | Online Article Text |
id | pubmed-6581719 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65817192019-06-26 Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids Ye, Qingmei Liu, Kai Shen, Qun Li, Qingyue Hao, Jinghui Han, Fangxuan Jiang, Ren-Wang Front Oncol Oncology Multidrug resistance (MDR) resulting from different defensive mechanisms in cancer is one of the major obstacles of clinical treatment. To circumvent MDR many reversal agents have been developed, but most of them fail in clinical trials due to severely adverse effects. Recently, certain natural products have been reported to overcome MDR, including flavonoids which are abundant in plants, foods, and herbs. The structure of flavonoids can be abbreviated as C6-C3-C6 (C for carbon), and further categorized into flavonoids, iso-flavonoids and neo-flavonoids, according to their structural backbones. Flavonoids possess multiple bioactivities, and a growing body of research has indicated that both flavonoids and iso-flavonoids can either kill or re-sensitize conventional chemotherapeutics to resistant cancer cells. Here, we summarize the research and discuss the underlying mechanisms, concluding that these flavonoids do not function as specific regulators of target proteins, but rather as multi-functional agents that negatively regulate the key factors contributing to MDR. Frontiers Media S.A. 2019-06-12 /pmc/articles/PMC6581719/ /pubmed/31245292 http://dx.doi.org/10.3389/fonc.2019.00487 Text en Copyright © 2019 Ye, Liu, Shen, Li, Hao, Han and Jiang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Ye, Qingmei Liu, Kai Shen, Qun Li, Qingyue Hao, Jinghui Han, Fangxuan Jiang, Ren-Wang Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids |
title | Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids |
title_full | Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids |
title_fullStr | Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids |
title_full_unstemmed | Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids |
title_short | Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids |
title_sort | reversal of multidrug resistance in cancer by multi-functional flavonoids |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581719/ https://www.ncbi.nlm.nih.gov/pubmed/31245292 http://dx.doi.org/10.3389/fonc.2019.00487 |
work_keys_str_mv | AT yeqingmei reversalofmultidrugresistanceincancerbymultifunctionalflavonoids AT liukai reversalofmultidrugresistanceincancerbymultifunctionalflavonoids AT shenqun reversalofmultidrugresistanceincancerbymultifunctionalflavonoids AT liqingyue reversalofmultidrugresistanceincancerbymultifunctionalflavonoids AT haojinghui reversalofmultidrugresistanceincancerbymultifunctionalflavonoids AT hanfangxuan reversalofmultidrugresistanceincancerbymultifunctionalflavonoids AT jiangrenwang reversalofmultidrugresistanceincancerbymultifunctionalflavonoids |